TECX Tectonic Therapeutic, Inc.
Healthcare$29.99+2.99%ClosedMarket Cap: $565.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.37
P/S
0.00
EV/EBITDA
-3.81
DCF Value
$13.73
FCF Yield
-11.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-32.3%
ROA
-33.9%
ROIC
-39.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-27.3M | $-25.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-21.5M | $-19.2M | $— | — |
| FY null | $0.00 | NaN% | $-84.0M | $-74.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-21.9M | $-19.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-22.3M | $-20.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-18.3M | $-15.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-14.0M | $-12.4M | $— | — |
| FY null | $0.00 | NaN% | $-58.0M | $-58.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-19.6M | $-17.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-11.4M | $-12.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-13.0M | $-15.2M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-9.4M | $-7.9M | $-2.36 | — |